GlaxoSmithKline Pharmaceuticals Limited conducted a postal ballot process through remote e-voting seeking shareholder approval for two ordinary resolutions regarding director appointments. The voting period commenced on Friday, August 14, 2026 at 09:00 AM and ended on Sunday, September 13, 2026 at 05:00 PM IST.
Resolution Details
Resolution 1: Appointment of Ms. Karine J F Natland (DIN:11870917) as Non-Executive Director
- Voted in favour: 891 members representing 14,30,66,813 shares (99.71% of valid votes)
- Voted against: 60 members representing 4,19,550 shares (0.29% of valid votes)
- Invalid votes: None
Resolution 2: Re-appointment of Mr. Bhushan Akshikar (DIN:09112346) as Managing Director
- Voted in favour: 881 members representing 14,30,25,237 shares (99.71% of valid votes)
- Voted against: 69 members representing 4,15,465 shares (0.29% of valid votes)
- Invalid votes: None
Process Details
The postal ballot was conducted pursuant to Section 110 of the Companies Act, 2013 read with the Companies (Management and Administration) Rules, 2014 as amended, and Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The cut-off date for determining shareholder eligibility was Friday, August 7, 2026. The company utilized the e-voting facility provided by KFin Technologies Limited (KFintech).
Scrutinizer Appointment
P.N. Parikh of Parikh & Associates (Membership No. FCS 327, CP No. 1228) was appointed as scrutinizer to conduct the postal ballot process. The scrutinizer maintained a register of e-votes and certified the voting results.